Amylyx Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Amylyx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amylyx Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Amylyx Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $487k | 36k | 13.59 |
| 2025-03-31 | $191k | 54k | 3.54 |
| 2024-12-31 | $210k | 56k | 3.78 |
| 2024-09-30 | $455k | 141k | 3.24 |
| 2024-06-30 | $109k | 58k | 1.90 |
| 2024-03-31 | $1.2M | 410k | 2.83 |
| 2023-12-31 | $1.1M | 72k | 14.72 |
| 2023-09-30 | $1.7M | 91k | 18.31 |
| 2023-06-30 | $4.1M | 190k | 21.57 |
| 2023-03-31 | $117M | 44k | 2688.37 |
| 2022-12-31 | $1.8M | 50k | 36.91 |
| 2022-06-30 | $118k | 6.1k | 19.24 |
| 2022-03-31 | $58k | 4.5k | 12.90 |